Cargando…
Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis
Autores principales: | Dalm, Virgil, Neeleman, Rochus, de Wit, Harm, Drexhage, Hemmo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716513/ http://dx.doi.org/10.1186/2045-7022-3-S2-P23 |
Ejemplares similares
-
Postoperative antibiotic use in patients with unilateral purulent chronic rhinosinusitis
por: Gordon, Alex, et al.
Publicado: (2021) -
Chronic rhinosinusitis with nasal polyps in the elderly
por: Cornet, Marjolein, et al.
Publicado: (2013) -
Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012) -
Impact of purulent complications and sepsis on cardiovascular system in patients with type 2 diabetes
por: Shalaeva, E, et al.
Publicado: (2014) -
Therapeutic Options for Chronic Rhinosinusitis in N-ERD Patients
por: van der Lans, Rik J. L., et al.
Publicado: (2021)